Cartesian Therapeutics Inc (RNAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 2,797 | 38,913 | 26,004 | 110,777 | 85,077 |
| Gross Profit | 2,797 | 38,913 | 26,004 | 110,777 | 85,077 |
| Operating Expenses | 146,202 | 82,810 | 112,420 | 96,239 | 89,674 |
| Operating Income | -143,405 | -43,897 | -86,416 | 14,538 | -4,597 |
| Interest Expense | 0 | 0 | 2,833 | 3,031 | 2,844 |
| Other Income | 3,910 | -33,240 | -149,461 | 23,263 | -2,280 |
| Pre-tax Income | -139,495 | -77,137 | -238,710 | 34,770 | -9,721 |
| Income Tax | -9,193 | 287 | -19,000 | -609 | 15,966 |
| Net Income Continuous | -130,302 | -77,424 | -219,710 | 35,379 | -25,687 |
| Net Income | $-130,302 | $-77,424 | $-219,710 | $35,379 | $-25,687 |
| EPS Basic Total Ops | -5.02 | -4.48 | -49.76 | 7.21 | -6.61 |
| EPS Basic Continuous Ops | -5.02 | -4.48 | -42.49 | 7.34 | -6.75 |
| EPS Diluted Total Ops | -5.02 | -4.49 | -49.76 | 3.00 | -6.61 |
| EPS Diluted Continuous Ops | -5.02 | -4.46 | -42.49 | 7.28 | -6.75 |
| EPS Diluted Before Non-Recurring Items | -2.84 | -4.49 | -10.21 | -2.40 | -6.01 |
| EBITDA(a) | $-140,446 | $-42,746 | $-85,652 | $15,450 | $-3,288 |